A detailed history of Cedar Mountain Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 46 shares of LLY stock, worth $36,600. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46
Previous 30 53.33%
Holding current value
$36,600
Previous $27,000 48.15%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $12,354 - $15,360
16 Added 53.33%
46 $40,000
Q2 2024

Jul 11, 2024

SELL
$724.87 - $909.04 $2,174 - $2,727
-3 Reduced 9.09%
30 $27,000
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $1,575 - $1,857
3 Added 10.0%
33 $19,000
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 New
30 $16,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.